# Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain

> **NCT02569073** · PHASE4 · WITHDRAWN · sponsor: **Temple University**

## Conditions studied

- Esophageal Diseases

## Interventions

- **DRUG:** Dronabinol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02569073
- **Lead sponsor:** Temple University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-06-21
- **Primary completion:** 2019-08-01
- **Final completion:** 2019-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding
- **Last updated:** 2019-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02569073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02569073, "Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02569073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*